Taltz — Medical Mutual

Initial criteria

• Patient is age ≥ 18 years
• Prescribed by or in consultation with a rheumatologist or a dermatologist

Reauthorization criteria

• Patient has been established on therapy for at least 6 months
• When assessed by at least one objective measure, patient experienced a beneficial clinical response from baseline OR compared with baseline patient experienced an improvement in at least one symptom such as less joint pain, morning stiffness, or fatigue; improved function or activities of daily living; decreased soft tissue swelling in joints or tendon sheaths

Approval duration

Initial: 6 months; Reauth: 1 year